HIGHLIGHTS
- who: Anna Maria Nurmi and collaborators from the Department of Surgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland, Department have published the article: The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy, in the Journal: PLOS ONE of April/29,/2021
- what: By studying TLRs in this setting the authors aimed to investigate the possible immunobiological effects of neoadjuvant therapy, in general, on tumor cells and look at the possible prognostic value TLRs have in PDAC. The authors show that TLRs 1, 3, and 9 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.